Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Soyasaponin Bb

Copy Product Info
😃Good
Catalog No. T3S0335Cas No. 51330-27-9
Alias Soyasaponin I

1. Soyasaponin Bb (Soyasaponin I) can suppress Eca-976 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.

Soyasaponin Bb

Soyasaponin Bb

Copy Product Info
😃Good
Purity: 99.62%
Catalog No. T3S0335Alias Soyasaponin ICas No. 51330-27-9
1. Soyasaponin Bb (Soyasaponin I) can suppress Eca-976 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$41In StockIn Stock
5 mg$96In StockIn Stock
10 mg$147In StockIn Stock
25 mg$248In StockIn Stock
50 mg$369In StockIn Stock
100 mg$547In StockIn Stock
200 mg$778InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.62%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Soyasaponin Bb AI Summary
Soyasaponin Bb exhibits a range of bioactivities with potential therapeutic implications. It has shown efficacy in inhibiting DMBA-induced/TPA-promoted carcinogenesis in mice by reducing the number of skin papillomas per mouse by 40.0% after 20 weeks in a two-stage carcinogenesis test. In LPS-stimulated mouse RAW264.7 cells, the compound inhibits inducible nitric oxide synthase (iNOS) mRNA expression and activity in a dose-dependent manner, reducing iNOS mRNA expression with fold changes of 11.1, 8.8, 6.8, and 5.6 at concentrations of 25, 50, 100, and 200 µg/ml, respectively, and decreasing iNOS activity proportionally. Additionally, Soyasaponin Bb acts as a PPARgamma agonist in human HepG2 cells, with luciferase reporter gene assays revealing fold changes of 1.22, 1.36, and 1.79 at concentrations of 12.5, 25, and 50 µg/ml, respectively, after 24 hours. The compound also shows inhibitory action on glycosyltransferase enzymes, inhibiting human alpha-2,6-ST6GAL1 by 68.0% at 100 µM, rat alpha-2,3-O-ST3GALI by 59.0% at 500 µM, and demonstrating strong inhibitory activity of 83.0% on the latter enzyme at 1 mM. Furthermore, Soyasaponin Bb displays hepatoprotective properties against D-GaIN/LPS-induced liver injury in rat hepatocytes, though its exhibited activity in this context was reported as 0.0%. These data suggest that Soyasaponin Bb could be of significant interest across multiple therapeutic areas, including carcinogenesis, inflammation modulation, metabolic disorders, and hepatoprotection..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
1. Soyasaponin Bb (Soyasaponin I) can suppress Eca-976 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.
SynonymsSoyasaponin I
Chemical Properties
Molecular Weight943.12
FormulaC48H78O18
Cas No.51330-27-9
Smiles[H][C@@]1(O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@]2([H])O[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@@]2([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])CC=C3[C@]5([H])CC(C)(C)C[C@@H](O)[C@]5(C)CC[C@@]43C)[C@@]2(C)CO)C(O)=O)O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
Relative Density.1.41g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (47.71 mM), Sonication is recommended.
Ethanol: 1 mg/mL (1.06 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (2.12 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM1.0603 mL5.3016 mL10.6031 mL53.0155 mL
DMSO
1mg5mg10mg50mg
5 mM0.2121 mL1.0603 mL2.1206 mL10.6031 mL
10 mM0.1060 mL0.5302 mL1.0603 mL5.3016 mL
20 mM0.0530 mL0.2651 mL0.5302 mL2.6508 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Soyasaponin Bb | purchase Soyasaponin Bb | Soyasaponin Bb cost | order Soyasaponin Bb | Soyasaponin Bb chemical structure | Soyasaponin Bb formula | Soyasaponin Bb molecular weight